Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Submitted by
admin
on January 31, 2012 - 7:47am
Source:
Seeking Alpha
News Tags:
Dendreon
Provenge
prostate cancer
JNJ
Zytiga
Headline:
Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
Do Not Allow Advertisers to Use My Personal information
